Show simple item record

dc.contributor.authorVidal Domènech, Francisco
dc.contributor.authorRiquelme, Gemma
dc.contributor.authorPinacho, Raquel
dc.contributor.authorRodríguez Mias, Ricard
dc.contributor.authorVera, América
dc.contributor.authorMonje, Alfonso
dc.contributor.authorFerrer, Isidre
dc.contributor.authorCallado Hernando, Luis Felipe ORCID
dc.contributor.authorMeana Martínez, José Javier ORCID
dc.contributor.authorVillén, Judit
dc.contributor.authorRamos, Belén
dc.date.accessioned2020-12-16T13:14:01Z
dc.date.available2020-12-16T13:14:01Z
dc.date.issued2020-07-08
dc.identifier.citationPlos One 15(7) : (2020) // Article ID e0230400es_ES
dc.identifier.issn1932-6203
dc.identifier.urihttp://hdl.handle.net/10810/49115
dc.description.abstractAlterations in the cortico-cerebellar-thalamic-cortical circuit might underlie the diversity of symptoms in schizophrenia. However, molecular changes in cerebellar neuronal circuits, part of this network, have not yet been fully determined. Using LC-MS/MS, we screened altered candidates in pooled grey matter of cerebellum from schizophrenia subjects who committed suicide (n = 4) and healthy individuals (n = 4). Further validation by immunoblotting of three selected candidates was performed in two cohorts comprising schizophrenia (n = 20), non-schizophrenia suicide (n = 6) and healthy controls (n = 21). We found 99 significantly altered proteins, 31 of them previously reported in other brain areas by proteomic studies. Transport function was the most enriched category, while cell communication was the most prevalent function. For validation, we selected the vacuolar proton pump subunit 1 (VPP1), from transport, and two EF-hand calcium-binding proteins, calmodulin and parvalbumin, from cell communication. All candidates showed significant changes in schizophrenia (n = 7) compared to controls (n = 7). VPP1 was altered in the non-schizophrenia suicide group and increased levels of parvalbumin were linked to antipsychotics. Further validation in an independent cohort of non-suicidal chronic schizophrenia subjects (n = 13) and non-psychiatric controls (n = 14) showed that parvalbumin was increased, while calmodulin was decreased in schizophrenia. Our findings provide evidence of calcium-binding protein dysregulation in the cerebellum in schizophrenia, suggesting an impact on normal calcium-dependent synaptic functioning of cerebellar circuits. Our study also links VPP1 to suicide behaviours, suggesting a possible impairment in vesicle neurotransmitter refilling and release in these phenotypes.es_ES
dc.description.sponsorshipCerrar texto de financiación This work was supported by a Miguel Servet grant (MS16/00153-CP16/00153) to BR financed and integrated into the National R + D + I and funded by the Instituto de Salud Carlos III (Spanish Ministry of Health) - General Branch Evaluation and Promotion of Health Research and the European Regional Development Fund (ERDF), the Basque Government (IT1211/19) and SAF 2017-88126-R to J.J.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.es_ES
dc.language.isoenges_ES
dc.publisherPublic Library Sciencees_ES
dc.relationinfo:eu-repo/grantAgreement/MINECO/SAF 2017-88126-Res_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectserotonin 5-HT2A receptorses_ES
dc.subjectpostmortem braines_ES
dc.subjectsubunit A1es_ES
dc.subjectH+ -ATPasees_ES
dc.subjectparvalbumines_ES
dc.subjectexpressiones_ES
dc.subjectcalmodulines_ES
dc.subjectsuicidees_ES
dc.subjectcalbindines_ES
dc.subjectneuronses_ES
dc.titleCalcium-binding proteins are altered in the cerebellum in schizophreniaes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder2020 Vidal-Domènech et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.es_ES
dc.rights.holderAtribución 3.0 España*
dc.relation.publisherversionhttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0230400es_ES
dc.identifier.doi10.1371/journal.pone.0230400
dc.departamentoesFarmacologíaes_ES
dc.departamentoeuFarmakologiaes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

2020 Vidal-Domènech et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Except where otherwise noted, this item's license is described as 2020 Vidal-Domènech et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.